دورية أكاديمية

Healthcare professionals' willingness to utilize a mobile health application for adverse drug reaction reporting in a limited resource setting: An input for digital health, 2023.

التفاصيل البيبلوغرافية
العنوان: Healthcare professionals' willingness to utilize a mobile health application for adverse drug reaction reporting in a limited resource setting: An input for digital health, 2023.
المؤلفون: Dubale AT; Department of Health Informatics, College of Health Science, Mattu University, Mattu, Ethiopia., Tareke AA; Deparment of Monitoring and Evaluation, West Gondar Zonal Health Department, Gondar, Ethiopia., Butta FW; Department of Health Informatics, College of Health Science, Mattu University, Mattu, Ethiopia., Shibabaw AA; Department of Health Informatics, College of Health Science, Mattu University, Mattu, Ethiopia.; Department of Midwifery, College of Health Science, Mattu University, Mattu, Ethiopia.; Department of Health Informatics, College of Health Science, Wallo University, Wallo, Ethiopia.; Deparment of Monitoring and Evaluation, West Gondar Zonal Health Department, Gondar, Ethiopia.; Department of Health Informatics, Asrat Woldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia., Eniyew EB; Department of Health Informatics, College of Health Science, Wallo University, Wallo, Ethiopia., Ahmed MH; Department of Health Informatics, College of Health Science, Mattu University, Mattu, Ethiopia., Kassie SY; Department of Health Informatics, College of Health Science, Mattu University, Mattu, Ethiopia., Demsash AW; Department of Health Informatics, College of Health Science, Mattu University, Mattu, Ethiopia., Chereka AA; Department of Health Informatics, College of Health Science, Mattu University, Mattu, Ethiopia., Dube GN; Department of Health Informatics, College of Health Science, Mattu University, Mattu, Ethiopia., Walle AD; Department of Health Informatics, Asrat Woldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia., Kitil GW; Department of Midwifery, College of Health Science, Mattu University, Mattu, Ethiopia.
المصدر: European journal of obstetrics & gynecology and reproductive biology: X [Eur J Obstet Gynecol Reprod Biol X] 2024 Jun 27; Vol. 23, pp. 100324. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101750520 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-1613 (Electronic) Linking ISSN: 25901613 NLM ISO Abbreviation: Eur J Obstet Gynecol Reprod Biol X Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Amsterdam] : Elsevier B.V., [2019]-
مستخلص: Background: Adverse drug reactions (ADRs) are a significant public health concern, particularly in limited resource settings where underreporting is prevalent due to various challenges. Mobile health applications (mHealth apps) offer a promising solution to enhance pharmacovigilance by facilitating easier and more efficient ADR reporting. However, despite the increasing availability and use of mHealth apps, there is a lack of evidence on healthcare professionals' willingness to adopt them for ADR reporting in resource-constrained environments. Therefore, this study aimed to assess the willingness of healthcare professionals in Ethiopia to utilize mobile health applications for adverse drug reaction reporting and identify associated factors.
Methods: We carried out a cross-sectional study involving 422 healthcare professionals working in institutional settings. We gathered data through a pretested questionnaire that participants completed themselves. We inputted the data using Epi Data V.4.6 and analyzed it using SPSS V.26. Our analysis involved conducting multivariable logistic regression to identify the factors influencing the likelihood of healthcare professionals using mobile applications to report adverse drug reactions.
Results: The study involved 389 healthcare professionals. Approximately 301 (77.4 %) of them expressed willingness to utilize mobile applications for reporting adverse drug reactions. The willingness to utilize mobile applications was significantly associated with the type of mobile phone (smart: AOR 3.56; 95 % CI 2.15-5.67), basic computer training (AOR 4.43; 95 % CI 2.27-8.64), mobile health-related training (AOR 1.96; 95 % CI 1.01-3.79), attitude (AOR 4.01; 95 % CI 2.19-7.35), perceived ease of use (AOR 2.91; 95 % CI 1.59-5.23), and perceived usefulness (AOR 2.10; 95 % CI 1.15-3.85).
Conclusions: Overall, there was a high proportion of healthcare professionals willing to use mobile devices for reporting drug adverse reactions. Their willingness correlated with factors such as the type of mobile phone, perceived ease of use, attitude, training, and perceived usefulness of mobile applications. With the increasing use of smartphones, motivation among healthcare professionals is rising. Basic computer and mHealth-related training are crucial for enhancing the acceptability of such applications and should be incorporated into future implementations. Taking these factors into account could offer insights into the design and implementation of mobile applications for adverse drug reactions in Ethiopia.
Competing Interests: The authors declare that they have no competing monetary interests or personal relationships that could have influenced the work reported in this paper.
(© 2024 The Authors.)
References: Drug Saf. 2016 Sep;39(9):847-57. (PMID: 27449638)
BMJ Open. 2014 Nov 24;4(11):e005869. (PMID: 25421337)
Mhealth. 2017 Nov 27;3:51. (PMID: 29430455)
Saudi Pharm J. 2017 Sep;25(6):830-837. (PMID: 28951666)
J Multidiscip Healthc. 2022 Jul 08;15:1445-1455. (PMID: 35837350)
Drug Saf. 2023 Jun;46(6):565-574. (PMID: 37097426)
Telemed J E Health. 2016 May;22(5):342-75. (PMID: 27128779)
Online J Public Health Inform. 2019 Sep 19;11(2):e10. (PMID: 31632604)
Ann Pharmacother. 2003 Feb;37(2):303-4; author reply 304-5. (PMID: 12549969)
BMC Med Inform Decis Mak. 2021 Jan 21;21(1):24. (PMID: 33478502)
J Infect Public Health. 2021 Jan;14(1):97-102. (PMID: 31060975)
BMJ Health Care Inform. 2023 May;30(1):. (PMID: 37236653)
Inform Med Unlocked. 2021;27:100783. (PMID: 34778509)
Biomed Res Int. 2020 Aug 26;2020:3827328. (PMID: 32908886)
J Natl Cancer Inst. 2014 Sep 29;106(9):. (PMID: 25265940)
Ann Fam Med. 2016 Jan-Feb;14(1):34-40. (PMID: 26755781)
World Health Organ Tech Rep Ser. 1969;425:5-24. (PMID: 4981079)
BMC Health Serv Res. 2019 Dec 3;19(1):926. (PMID: 31796034)
Indian Pediatr. 2020 Apr 15;57(4):356-358. (PMID: 32284477)
JMIR Mhealth Uhealth. 2019 Jul 03;7(7):e12900. (PMID: 31271150)
BMJ. 2004 Jul 3;329(7456):15-9. (PMID: 15231615)
Biomed Res Int. 2023 Apr 17;2023:4148211. (PMID: 37101688)
Drug Saf. 2017 May;40(5):443-455. (PMID: 28035492)
JMIR Med Educ. 2021 Feb 19;7(1):e18590. (PMID: 33605896)
فهرسة مساهمة: Keywords: Adverse drug reaction; Ethiopia; Healthcare professionals; MHealth application
تواريخ الأحداث: Date Created: 20240725 Latest Revision: 20240726
رمز التحديث: 20240726
مُعرف محوري في PubMed: PMC11268114
DOI: 10.1016/j.eurox.2024.100324
PMID: 39050924
قاعدة البيانات: MEDLINE
الوصف
تدمد:2590-1613
DOI:10.1016/j.eurox.2024.100324